Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VAPB anticorps (AA 51-150) (Biotin)

VAPB Reactivité: Rat WB, ELISA, IHC (p), IHC (fro) Hôte: Lapin Polyclonal Biotin
N° du produit ABIN705538
  • Antigène Voir toutes VAPB Anticorps
    VAPB (VAMP (Vesicle-Associated Membrane Protein)-Associated Protein B and C (VAPB))
    Épitope
    • 14
    • 8
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 51-150
    Reactivité
    • 44
    • 20
    • 10
    • 1
    • 1
    • 1
    • 1
    • 1
    Rat
    Hôte
    • 50
    • 7
    • 1
    Lapin
    Clonalité
    • 53
    • 5
    Polyclonal
    Conjugué
    • 28
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp VAPB est conjugé à/à la Biotin
    Application
    • 50
    • 23
    • 13
    • 13
    • 11
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
     Réactivité croisée
    Rat
    Homologie
    Human,Mouse,Cow,Sheep,Pig,Horse,Chicken,Rabbit
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human VAPB
    Isotype
    IgG
    Top Product
    Discover our top product VAPB Anticorps primaire
  • Indications d'application
    WB 1:300-5000
    IHC-P 1:200-400
    IHC-F 1:100-500
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C for 12 months.
    Date de péremption
    12 months
  • Antigène
    VAPB (VAMP (Vesicle-Associated Membrane Protein)-Associated Protein B and C (VAPB))
    Autre désignation
    VAPB (VAPB Produits)
    Synonymes
    anticorps ALS8, anticorps VAMP-B, anticorps VAP-B, anticorps AI225786, anticorps AI840687, anticorps AI848259, anticorps D2Abb2e, anticorps R75548, anticorps VAP33b, anticorps Vamp33b, anticorps fc05d09, anticorps wu:fa96d05, anticorps wu:fc05d09, anticorps zgc:66045, anticorps vamp-b, anticorps vamp-c, anticorps vap-b, anticorps vap-c, anticorps vapb, anticorps VAMP associated protein B and C, anticorps vesicle-associated membrane protein-associated protein B/C, anticorps vesicle-associated membrane protein, associated protein B and C, anticorps VAMP (vesicle-associated membrane protein)-associated protein B and C, anticorps VAMP (vesicle-associated membrane protein)-associated protein B and C L homeolog, anticorps VAPB, anticorps Tsp_07972, anticorps Vapb, anticorps vapb, anticorps vapb.L
    Sujet

    Synonyms: ALS 8, ALS8, D2Abb2e, UNQ484/PRO983, Vamp 33b, VAMP associated 33 kDa protein, VAMP associated protein B and C, VAMP associated protein B, VAMP associated protein B/C, VAMP associated protein C, VAMP B, VAMP B VAMP C, VAMP B/VAMP C, VAMP C, VAMP vesicle associated membrane protein associated protein B and C, Vamp33b, VAMPB, VAMPB/VAMPC, VAMPC, VAP 33b, VAP B, VAP B/VAP C, VAP C, VAP33b, VAPB/VAPC, VAPC antibody Vesicle associated membrane protein associated protein B and C, Vesicle associated membrane protein associated protein B/C, VAPB_HUMAN.

    Background: VAPB contains 1 MSP domain and it may play a role in vesicle trafficking. Defects in VAPB are a cause of proximal adult autosomal dominant spinal muscular atrophy [MIM:182980], also called late onset spinal muscular atrophy Finkel type. Spinal muscular atrophies are neurodegenerative disorders characterized by degeneration of lower motor neurons, leading to progressive paralysis muscular atrophy. This form is a late adult onset form of the disease (after age 20 years). The patients show a benign course, most of them remaining ambulatory 10 to 40 years after clinical onset.

    ID gène
    9217
    Pathways
    ER-Nucleus Signaling
Vous êtes ici:
Support technique